Diferencia entre revisiones de «Camphor toxicity»
Sin resumen de edición |
|||
| Línea 11: | Línea 11: | ||
*Seizure, respiratory depression, coma | *Seizure, respiratory depression, coma | ||
*Hepatitis and liver failure | *Hepatitis and liver failure | ||
==Differential Diagnosis== | |||
==Evaluation== | |||
==Management== | ==Management== | ||
| Línea 17: | Línea 23: | ||
*Intubation and mechanical ventilation as needed | *Intubation and mechanical ventilation as needed | ||
*Charcoal not likely effective | *Charcoal not likely effective | ||
==Disposition== | |||
==See Also== | ==See Also== | ||
==References== | ==References== | ||
Revisión del 05:53 7 sep 2017
Background
- Common topical agent for pain relief, wart removal, osteoarthritis, cold sores, cough suppression, nasal decongestion
- FDA limits over the counter preparations to 11%[1]
- Highly lipophilic, widely and rapidly distributed, symptom onset 5-15 minutes
- CNS stimulant when ingested
Clinical Features
- Nausea, vomiting, abdominal pain
- Oral burning, headache
- Vertigo, confusion, agitation
- Seizure, respiratory depression, coma
- Hepatitis and liver failure
Differential Diagnosis
Evaluation
Management
- Aggressive supportive care[2]
- Benzodiazepines for seizure
- Intubation and mechanical ventilation as needed
- Charcoal not likely effective